Failure to properly treat patients suffering legitimate chronic pain syndromes can result in a compounding of prescription pain-medication abuse.
Pain is the one concern that more often than not prompts people to see a health-care provider, so adequately addressing these complaints can significantly influence the relationship you have with your patients.
Although Fibromyalgia is one of the most prevalent chronic pain diagnoses in the United States, no single laboratory or physical exam will help clinicians identify the disorder, a speaker told audiences at the American Academy of Nurse Practitioners 26th Annual NP meeting.
Researchers at the American Pain Society’s 30th Annual Scientific Meeting discussed data from a review of spontaneous adverse events reported with Embeda (morphine sulfate and naltrexone HCl) treatment, with a focus on events potentially related to product tampering.
Fulranumab no more efficacious than placebo for treating patients with chronic low back pain.